Pathway to discovery in rare disease
Sanofi researchers are investigating a metabolic hub that plays a key role in three classes of rare disease
The Fight against COVID-19
As the pandemic continues, Sanofi is at the forefront of vaccine development, while carrying on the daily business of making and delivering medicines for patients
Giving Voice to All Breast Cancer Patients
"People tell me, you can’t save the world and I say, yes, I can. I do it every day, one person at a time" -Maimah Karmo, founder of the Tigerlily Foundation
-
Press releases2020-10-29MMMM DD YYYYEuropean Patent Office rules in favor of Sanofi and Regeneron concerning Praluent® (alirocumab)
